指南与共识质量管理与危急值

IFCC实验室误差与患者安全工作组关于全球采用基本质量指标面板的建议

Recommendations from the IFCC Working Group on Laboratory Errors and Patient Safety for the Global Adoption of an Essential Quality Indicators Panel in Laboratory Medicine.
指南 / 共识 · Clin Chem Lab Med · 2025-11-20

该建议通过共识会议更新IFCC质量指标模型,确定六项覆盖检验全流程的基本质量指标(QI),聚焦患者安全与临床结局。推荐了计算、报告频率及纳入IFCC和国家比对方案的方法,以促进标准化和数据整合。

要点

  • 六项基本QI覆盖检验前、中、后全流程,包括标识错误、样本拒收、溶血、EQA不合格、肌钙蛋白周转时间和报告错误。
  • 推荐将这些QI纳入IFCC质量指标平台和国家比对方案,以支持数据整合和质量规范制定。
  • QI选择优先考虑患者伤害概率、可检测性和数据收集可行性。

核心结论

  • 提出的基本QI面板提供标准化且可行的框架,支持纳入国家比对方案和IFCC MQI平台,促进患者安全持续改进。

研究设计与样本

  • 通过共识会议,多国专家审查IFCC质量指标模型(MQI)以识别高优先级指标,选择优先考虑患者伤害概率、可检测性及数据收集实施可行性。

主要发现

  • 确定并批准六项覆盖检验全流程的基本QI:错误标识申请率(Pre-MisR)和错误标识样本率(Pre-MisS);样本拒收率(Pre-RejS);溶血率(自动溶血指数Pre-HemI或视觉检查Pre-HemV);EQA/PT不可接受结果率(Intra-Unac);急诊肌钙蛋白第90百分位周转时间(Post-TnTAT, Post-TnTAT clin);错误实验室报告率(Post-RectRep)。

关键数值与推荐

  • 六项基本QI的具体定义和计算方式见原文推荐,报告频率及纳入IFCC和国家比对方案的建议已提供。

临床怎么用

  • 实验室可将六项基本QI纳入常规质量监测,参与IFCC MQI平台和国家比对方案,以促进数据整合和患者安全改进。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To maximize participation in the international standardization effort, this recommendation aims to update the international guidance of the Working Group on Laboratory Errors and Patient Safety of the International Federation of Clinical Chemistry and Laboratory Medicine by identifying a limited and globally applicable panel of Essential Quality Indicators (QIs) focused on patient safety, clinical outcomes, and harmonization across medical laboratories. METHODS: Through a consensus meeting, experts from multiple countries reviewed the IFCC Model of Quality Indicators (MQI) to identify high-priority indicators. Selection prioritized the probability of patient harm, ease of detection, and feasibility of data collection and implementation within national contexts. RESULTS: Six essential QIs covering the total testing process were identified and ratified: (1) rate of misidentified requests (Pre-MisR) and misidentified samples (Pre-MisS); (2) rate of sample rejections (Pre-RejS); (3) rate of hemolysis detected either by automated hemolysis index (Pre-HemI) or visual inspection (Pre-HemV); (4) rate of unacceptable results in External Quality Assessment/Proficiency Testing (Intra-Unac); (5) turnaround time of cardiac troponin at the 90th percentile for the emergency room (Post-TnTAT, Post-TnTAT clin); and (6) rate of incorrect laboratory reports (Post-RectRep). Recommendations on calculation, reporting frequency, and integration into IFCC and national comparison programs are provided. CONCLUSIONS: The proposed essential QI panel provides a standardized and feasible framework to support its integration into national comparison programs and the IFCC MQI platform. Its implementation will facilitate data consolidation, strengthen the development of national and global quality specifications, and contribute to continuous improvement in patient safety.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. De Guire V, Galoro CAO, Ibarz M, et al. Recommendations from the IFCC Working Group on Laboratory Errors and Patient Safety for the Global Adoption of an Essential Quality Indicators Panel in Laboratory Medicine. Clin Chem Lab Med. 2025. PMID: 41259049. doi:10.1515/cclm-2025-1462

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。